BFM 89.9

HIGHLIGHTS 
Podcast  >  Bigger Picture  >  Health & Living  >  Phages v. Antibiotic-Resistant Bacteria: Who Will Win?

Phages v. Antibiotic-Resistant Bacteria: Who Will Win?

Dr Tobi Nagel, Founder and President, Phages for Global Health

18-Dec-24 16:00

Phages v. Antibiotic-Resistant Bacteria: Who Will Win?

We’ve heard about “superbugs” - bacteria that are resistant to multiple types of antibiotics that were previously effective in treating infections. It is estimated that superbugs will kill about 10 million people each year, because of multi-drug resistance. But have you heard of something even deadlier than bacteria, yet could save us? These are bacteriophages, or phages, which target and destroy bacteria, including antibiotic-resistant bacteria. Dr Tobi Nagel, Founder and President, Phages for Global Health, tells us more about how phages could help us in this fight against antibiotic resistance, and what efforts are needed to ensure that phage therapy is accessible to low- and middle-income countries.

Image credit: Shutterstock

Produced by: Tee Shiao Eek

Presented by: Tee Shiao Eek


This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  medical advanceswellness

Tags:  the bigger picturehealth and livingantibiotic resistanceantimicrobial resistancephage





Play / Pause

Listen now : The 6AM Stretch: Thought-provoking discussions on ideas, people and events shaping our...

Today’s Shows



6:00 AM

The 6AM Stretch

Thought-provoking discussions on ideas, people and events shaping our lives.

7:00 AM

World Market Watch

Vishnu Varathan, Head of Economics & Strategy, Mizuho Bank tells us where international markets are heading.

7:15 AM

Morning Brief

We recap global and local headlines from today's papers and portals.

7:30 AM

Morning Brief

Christopher Wong, FX Strategist, OCBC Bank gives us an outlook for Asia FX.

7:45 AM

Morning Brief

Dr. Deborah Elms, Head of Trade Policy at the Hinrich Foundation explains the impact of the Supreme Court delaying its ruling on Trump’s tariffs and the resulting US-EU trade tensions.

8:00 AM

The Breakfast Grille

Edison Kong, Managing Director of Solar District Cooling Group Berhad, reflects on the company’s first year as a listed entity and its shift toward long-term recurring energy solutions.

8:30 AM

Morning Brief

Professor Dr Joanne Lim, Dean of the Faculty of Arts and Social Sciences at the University of Nottingham Malaysia, examines why a Freedom of Information Act matters and what meaningful transparency could look like at the federal level.

8:45 AM

Morning Brief

Dr. Renard Siew, Climate Change and Sustainability expert, discusses implications of the proposed national climate change bill.

9:00 AM

Opening Bell

(REPEAT) Vishnu Varathan, Head of Economics & Strategy, Mizuho Bank tells us where international markets are heading.

9:15 AM

Opening Bell

(REPEAT) Christopher Wong, FX Strategist, OCBC Bank gives us an outlook for Asia FX.

9:35 AM

Ringgit & Sense

Rajen Devadason, licensed financial planner talks about EPF's Retirement Income Adequacy framework.

10:05 AM

Open For Business

11:00 AM

Tech Talk

Quantum risk is no longer theoretical. As quantum computing threatens today’s encryption, banks and governments face urgent decisions. Wo Swee Teck, Managing Director of Securemetric Technology, discusses why PQC matters now, what NACSA’s directive means for Malaysia, and how organisations can move from legacy encryption to quantum-safe security.

12:00 PM

Enterprise Explores

1:00 PM

The Breakfast Grille Repeat

Edison Kong, Managing Director of Solar District Cooling Group Berhad, reflects on the company’s first year as a listed entity and its shift toward long-term recurring energy solutions.

2:05 PM

Discovery Hour

An eclectic selection of BBC shows, curated with variety in mind.

3:05 PM

Beyond the Ballot Box

An expert shares the key problems with our urban planning & design today and key principles to build an equitable city for everyone.

4:05 PM

Health & Living

A U.S.-Malaysia trade deal signed last year dictates that medical devices and pharmaceuticals from the U.S. no longer need local approval in Malaysia. We speak to an expert about what this means for us.

5:00 PM

Top 5 at 5

A countdown of the 5 biggest stories of the day, to catch you up on all you need to know!

6:00 PM

Talkback Thursday